Cost of cancer care varies widely based on who pays the bill
the ONA take:
Cost disparities in chemotherapy drugs can be substantial, reveals a new study from the University of North Carolina and Chapel Hill.
Researchers found uninsured patients with cancer are asked to pay on average 2 times more than Medicare recipients would pay for the same drugs, and that difference can go as high as 43 times more. The uninsured even pay more than those with private insurance.
Cost of doctor visits for cancer patients was also reviewed, and the same discrepancy in costs was seen. For example, uninsured patients were billed $129 to $391, depending on the complexity of the visit; however, Medicare and private insurance paid $65 to $188 and $78 to $246, respectively, for the same visits.
Researchers report that patients with Medicare or private insurance are paying a discounted rate for their health care. Uninsured patients do not have the bargaining power, or may not try to negotiate price on their own.
Uninsured patients with cancer are asked to pay on average 2 times more than Medicare recipients would pay for the same drugs
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Apalutamide Prolongs Time to Metastasis in Castration-resistant Prostate Cancer
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|